BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8395319)

  • 41. [An analysis on prognostic factors of hilar cholangiocarcinoma].
    Zhou LX; Zhang ZW; Xu ZY
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.
    Havlik R; Sbisà E; Tullo A; Kelly MD; Mitry RR; Jiao LR; Mansour MR; Honda K; Habib NA
    Hepatogastroenterology; 2000; 47(34):927-31. PubMed ID: 11020850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases.
    Zhang BH; Cheng QB; Luo XJ; Zhang YJ; Jiang XQ; Zhang BH; Yi B; Yu WL; Wu MC
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):278-82. PubMed ID: 16698591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognostic factors after surgical resection for hilar cholangiocarcinoma].
    Ramacciato G; Corigliano N; Mercantini P; Di Benedetto F; Masetti M; Ercolani G; Lauro A; De Ruvo N; Pinna AD
    Ann Chir; 2006; 131(6-7):379-85. PubMed ID: 16806037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival and an overview of decision-making in patients with cholangiocarcinoma.
    Forsmo HM; Horn A; Viste A; Hoem D; Ovrebo K
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):412-7. PubMed ID: 18693178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection.
    Miyazaki M; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I
    J Hepatobiliary Pancreat Surg; 2007; 14(5):463-8. PubMed ID: 17909714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Segmental liver resections for hilar cholangiocarcinoma.
    Nagino M; Nimura Y; Kamiya J; Kanai M; Uesaka K; Hayakawa N; Yamamoto H; Kondo S; Nishio H
    Hepatogastroenterology; 1998; 45(19):7-13. PubMed ID: 9496478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraductal papillary neoplasm of the bile ducts: the clinical features and surgical outcome of 25 cases.
    Paik KY; Heo JS; Choi SH; Choi DW
    J Surg Oncol; 2008 May; 97(6):508-12. PubMed ID: 18314868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical treatment of hilar bile duct carcinoma. Clinical and pathological studies.
    Huang ZQ; Zhou NX; Liu YX; Li WH; Yu G
    Chin Med J (Engl); 1992 Aug; 105(8):635-40. PubMed ID: 1458965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical treatment of hilar carcinoma of the bile duct.
    Mizumoto R; Kawarada Y; Suzuki H
    Surg Gynecol Obstet; 1986 Feb; 162(2):153-8. PubMed ID: 3945893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Carcinoma of the hilar bile duct: a clinical and pathological study].
    Li WH
    Zhonghua Wai Ke Za Zhi; 1993 Sep; 31(9):536-8. PubMed ID: 8033716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical treatment for carcinoma at the confluence of the major hepatic ducts.
    Iwasaki Y; Okamura T; Ozaki A; Todoroki T; Takase Y; Ohara K; Nishimura A; Otsu H
    Surg Gynecol Obstet; 1986 May; 162(5):457-64. PubMed ID: 3704902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and treatment of cholangiocellular carcinoma of the liver.
    Kawarada Y; Mizumoto R
    Hepatogastroenterology; 1990 Apr; 37(2):176-81. PubMed ID: 2160420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinicopathological features of biliary intraductal papillary neoplasms according to the location of tumors.
    Choi SC; Lee JK; Jung JH; Lee JS; Lee KH; Lee KT; Rhee JC; Jang KT; Choi SH; Heo JS; Choi DW; Lim JH
    J Gastroenterol Hepatol; 2010 Apr; 25(4):725-30. PubMed ID: 20492329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Surgical treatment of hilar bile duct carcinoma].
    Huang ZQ
    Zhonghua Wai Ke Za Zhi; 1990 Sep; 28(9):522-6, 572. PubMed ID: 2086122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Local resection for the treatment of carcinoma of the papilla of Vater].
    Huang YT; Xing MR
    Zhonghua Wai Ke Za Zhi; 1994 Oct; 32(10):603-5. PubMed ID: 7750418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neoplasm of the hepatic hilum: the role of resection.
    Gazzaniga GM; Filauro M; Bagarolo C; Ciferri E; Bondanza G
    Hepatogastroenterology; 1993 Jun; 40(3):244-8. PubMed ID: 7686876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Intrahepatic biliary-jejunal anastomosis in perihilar bile duct carcinoma].
    Huang JF
    Zhonghua Wai Ke Za Zhi; 1990 Sep; 28(9):527-9, 572-3. PubMed ID: 2086123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.